 "Cognizant To Buy marketRx For $135 Mn")
Cognizant Technology Solutions has signed a definitive agreement to acquire the US-based marketRx for $135 million.
This acquisition strengthens Cognizant’s full-suite of offerings across all areas of the life sciences value chain-from research and development and manufacturing to sales and marketing operations, the company said in a statement.
“This acquisition expands our capabilities in the analytics segment and broadens our service offerings for the life sciences industry, while providing strong synergies with our existing business intelligence/data warehousing and customer relationship management services,” said Francisco D’Souza, president and CEO, Cognizant.
marketRx, based in New Jersey, is engaged in analytics and related software services to pharmaceutical, biotechnology and medical devices companies.
IANS